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Voxel-based morphometryCognitive function decline secondary to cardiovascular disease has been reported. However, little is known about
the impact of coronary artery disease (CAD) on the aging brain macrostructure or whether exercise training,
in the context of cardiovascular rehabilitation, can affect brain structure following a coronary event. This study
employed voxel-based morphometry of high resolution structural MRI images to investigate; 1) changes in
regional gray matter volume (GMV) in CAD patients compared to age-matched controls, and 2) the effects of a
six-month exercise-based cardiovascular rehabilitation program on CAD-related GMV decline. Compared to
controls, signiﬁcant decreases in regional GMV were found in the superior, medial and inferior frontal gyrus;
superior and inferior parietal gyrus; middle and superior temporal gyrus and in the posterior cerebellum of
CAD patients. Cardiovascular rehabilitation was associated with the recovery of regional GMV in the superior
frontal gyrus, superior temporal gyrus and posterior cerebellum of the CAD patients as well as the increase in
GMV in the supplementarymotor area. Total and regional GMV correlatedwith ﬁtness level, deﬁned by themax-
imal oxygen consumption (VO2max), at baseline but not after cardiovascular rehabilitation. This study demon-
strates that cardiovascular disease can adversely affect age-related decline in GMV; and that these disease-
related effects could be mitigated bymoderate levels of exercise training as part of cardiovascular rehabilitation.
© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license. 1. Introduction
According to the Institute of Medicine, the age standardized mortal-
ity rate from cardiovascular disease has declined steadily over the past
50 years in industrialized nations (IOM (Institute of Medicine), 2010).
Much of the decline can be attributed to effective management of risk
factors associated with the disease. However, in the developed world,
cardiovascular disease still remains the most prevalent chronic disease
in individuals over the age of 50, and the debilitating effects of theiovascular rehabilitation; GMV,
Montreal Cognitive Assessment;
n consumption.
nstitute, 268 Grosvenor Street,
32; fax: +1 519 646 6205.
azodo).
.Open access under CC BY-NC-ND licedisease are evident by the high rate of hospitalization among this pa-
tient group (World Health Organization (WHO), 2011). Therefore,
there is heightened urgency to understanding the impact of cardiovas-
cular disease on ‘successful aging’, particularly given that the number
of adults over the age of 60 is steadily increasing.
One growing concern is the potential link between cardiovascular
disease risk factors and neurological impairment in older adults. Hyper-
tension, diabetes and hyperlipidemia have been independently linked
to abnormal changes in morphology and function of the aging brain
(De Toledo Ferraz Alves et al., 2010). Older individuals with higher
estimated risk of coronary artery disease (CAD) tend to have decreased
brain volume, cerebral blood ﬂow, and glucosemetabolism in regions of
the brain associatedwith cognitive function and, as such, are at a greater
risk of dementia (De Toledo Ferraz Alves et al., 2010). Even in older
adults with no clinical diagnosis of cardiovascular disease, decline
in cardiac function is associated with deﬁcits in cognitive function
(Jefferson et al., 2007a), brain atrophy (Jefferson, 2010) and white
matter hyperintensity (Jefferson et al., 2007b).
Despite the above studies involving cardiovascular risk factors, there
have been no similar studies on the impact of cardiovascular disease,nse. 
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morphology. Coronary artery disease is the most common form of car-
diovascular disease in adults over 50 years old with known pathophys-
iology (Chilton, 2004) and effective management strategies (Pﬂieger
et al., 2011). Physical activity is one of the most powerful and readily
available interventions with proven efﬁcacy in preventing secondary
CAD. Physical activity, speciﬁcally aerobic ﬁtness has been shown to im-
prove coronary ﬂow, lower the risk of myocardial reinfarction, lower
mortality rates, and improve overall cardiac function (Shephard and
Balady, 1999). Consequently, increased levels of physical activity are in-
creasingly prescribed as part of the clinicalmanagement for CAD (Smith
et al., 2011). In older adults, physical activity has also been associated
with improved cognitive function (Colcombe et al., 2004), decreased
risk for dementia (Larson et al., 2006) and reversal of cortical decline
(Colcombe et al., 2006).
These observations highlight the need to investigate the association
between CAD and brain structure and whether interventions, such as
physical activity, can reverse any adverse disease-related effects. The ob-
jectives of this studywere twofold: 1) to investigate potential differences
in regional gray matter volume in patients recently diagnosed with CAD
compared to controls, and 2) to determine if a standard cardiac rehabil-
itation regimen would reverse CAD-related structural changes.
2. Methods
2.1. Participants
This study was approved by theWestern University Health Sciences
Research Ethics Board, and written informed consent was obtained
from all subjects. CAD patients were recruited from the London Health
Sciences Centre for Cardiac Rehabilitation and Secondary Prevention
program following recent diagnosis of one of the following: acute coro-
nary syndrome (ST elevation or non-ST elevation myocardial infarct),
angina, percutaneous coronary intervention, or coronary artery bypass
surgery. Patients were excluded if they had congenital coronary abnor-
mality, cardiomyopathy, severe congestive heart failure, second or
third-degree atrioventricular block, more than two myocardial infarcts,
sick sinus syndrome, or major arrhythmias. Patients with uncontrolled
hypertension or a history of diabetes for more than 5 years were also
excluded. Age-matched control subjects included in this study had
no clinical diagnosis of cardiovascular disease, were non-smokers, and
did not have hypertension or diabetes. Both patients and controls
were free of any neurological condition or disease.
2.2. Clinical assessments of health
The relevant clinical markers of CADmeasured in all subjects are de-
scribed below. A standard three-lead electrocardiogramwas conducted
after 20 min of supine rest. Blood pressure was continuously measured
during electrocardiogram using a Finometer, which was calibrated
against periodic sphygmomanometric measurements (Dinamp, GE
Healthcare, Finland). Blood-borne markers of vascular disease namely:
plasma lipids, cholesterol, high-sensitivity C-reactive protein (hsCRP)
and glucose, were collected under fasting conditions. A Doppler echo-
cardiography (GE/Vingmed System FiVe Doppler) was completed
prior to cardio-respiratory exercise stress testing to assess left ventricu-
lar ejection fraction, left ventricularmass and left ventricular contractil-
ity. A test of global or overall cognitive functionwas performedwith the
Montreal Cognitive Assessment, MoCA (http://www.mocatest.org/).
Cardiorespiratory ﬁtness was measured by a graded exercise test in
which subjects were tested to volitional exhaustion under standard
clinical observation (ACSM, 1995). Breath-by-breath measurements of
oxygen consumption (VO2), heart rate and blood pressure were record-
ed throughout the test. Maximal oxygen consumption (VO2max) is an
establishedmarker of cardiorespiratory ﬁtness and a clinically acceptedsurrogatemaker for left ventricular function (Fletcher et al., 2001). Each
subject's VO2max was estimated from the graded exercise test.
2.3. Clinical assessment of cardiac rehabilitation
The aerobic exercise component of the cardiac rehabilitation (CR)
program was performed according to current guidelines (Stone et al.,
2009) at an intensity of 40–70% of heart rate reserve (i.e., the difference
maximum between the age-predicted and resting heart rates)
(Karvonen et al., 1957), or at a rate corresponding to an exertion
score of 11–14 on the Borg scale (Borg, 1982). Aerobic exercise
was performed a minimum of 3 days per week at a duration of
20-to-30 min per session.
2.4. MRI data acquisition
Whole-brain MRI images were acquired on two Siemens 3 T
MAGNETOM® Verio systems (Siemens Medical Systems, Erlangen,
Germany) equipped with 32-channel head array coils. Sagittal T1-
weighted imageswere acquired on each subject for graymatter volumet-
ric analysis using a three-dimensional (3D) magnetization-prepared
rapid gradient-echo imaging sequence (isotropic voxel resolution=
1.0 mm3; repetition time, echo time and inversion time= 2000, 2.98
and 900 ms, respectively; acceleration factor = 3; and ﬂip angle = 9°).
2.5. Voxel-based morphometry analysis
2.5.1. Effect of disease
T1-weighted images were segmented into gray matter (GM), white
matter (WM) and cerebrospinal ﬂuid (CSF) using the segmentation
option in SPM8 (http://www.ﬁl.ion.ucl.ac.uk). The tissue segments
were then afﬁne-registered to their respective Montreal Neurological
Institute (MNI) tissue probability maps, averaged and smoothed with
a 12-mm ﬁlter using DARTEL to create a study-speciﬁc template
(Ashburner, 2007). The individual GM images were spatially normal-
ized to this template using a high-dimensional DARTEL registration
and then multiplied by the Jacobian determinant (i.e., modulation) to
correct for nonlinear differences in individual brain size. Finally, the
GM images were smoothed with an 8-mm Gaussian ﬁlter. Local differ-
ences in GM volume (GMV) between groups were investigated with a
gender-by-group two-factor analysis of variance, performed on the
smoothed GMV images. An absolute threshold mask set at 0.1 was
used to remove non-GM and extra-cranial effects. A signiﬁcant positive
effect of disease was identiﬁed at voxel levels that differed between
groups at p b 0.05 after correction for multiple comparisons using the
false discovery rate (FDR) (Genovese et al., 2002).
2.5.2. Effect of rehabilitation
Pre and post CR T1-weighted images of the CAD patients were ana-
lyzed with the default options of the longitudinal module found in the
VBM8 toolbox of SPM8. Brieﬂy, each subject's data were analyzed in a
series of steps that included: 1) intra-subject registration, 2) intra-
subject bias correction, 3) segmentation, 4) non-linear DARTEL regis-
tration to study-speciﬁc template, 5) modulation of GM segments,
and 6) spatial smoothingwith an 8 mmGaussianﬁlter. A repeatedmea-
sures analysis of variance of the change in GM volume over time was
performed on the smoothed GM image with a within-subject factor of
time and between-subject factor of scanner. Gender-by-time analysis
of variance was also explored. A positive signiﬁcant change was identi-
ﬁed at voxel levels that showed positive change in volume for p b 0.05
after correction for multiple comparisons using the more stringent
family wise error (FWE) (Genovese et al., 2002). An absolute threshold
mask was also set at 0.1.
To investigate evidence of GMV recovery with CR, binary masks of
regions of interests (ROIs) were created using the MarsBaR ROI toolbox
(http://marsbar.sourceforge.net) from clusters of voxels that showed
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controls (see Table 2) with minimum voxel clusters of 50 contiguous
voxels. Small volume correctionwas performed in SPM8on contrast im-
ages from the repeated analysis of variance with the ROIs to restrict
multiple comparisons to a smaller number of voxels, which reduced
type II errors. Areas of GM recovery are reported as signiﬁcant if clusters
survive FWE correction at p b 0.05.
2.5.3. Statistical analysis
Statistical analyses were conducted with SPSS 20.0 statistical soft-
ware (IBM Corp. Armonk, NY, and USA). Clinical assessments from the
control group was compared to baseline data from the CAD patient
group using a one-way multivariate analysis of variance to test for dif-
ferences in cardiovascular health and cognitive function. Clinical param-
eters entered into the multivariate analysis for cardiovascular health
include all variables listed in Table 1 except for age, gender, MoCA and
VO2max. Gender differences between groups was assessed by gender-
by-group interaction and simple main effects of gender. Signiﬁcant
interaction and main effects are reported at p b 0.05. Spearman rank
correlation analysis was performed between baseline total gray
matter/ROI volumes and baselineMoCA scores, VO2max and other clin-
ical measures collected to investigate the association between overall
cognition, ﬁtness level, cardiovascular health, and brain atrophy. Total
gray matter volume in mm3 for each subject was obtained from the
VBM8 segmentation output, while mean values of regional gray matter
volume were extracted from voxel clusters that showed signiﬁcant dif-
ference between groups for each subject using MarsBaR, as described
earlier.
A paired t-test was conducted on the clinical variables collected on
the CAD patients pre and post CR to test for a difference between the
means (p b 0.05). To test for association between ﬁtness level and
GMV post CR, a Spearman rank correlation analysis was performed be-
tween VO2max and total gray matter/ROI volumes obtained from post
CR data, and between change in GMV and change in VO2max post CR.
3. Results
3.1. Cardiovascular disease effects
A total of 41 CAD patients and 21 controls participated in the study;
their characteristics are provided in Table 1. Data from three controls
and two CAD patients data were removed because of neurological inci-
dental ﬁndings in the MRI data. Data from 36 patients and all controls
were collected on one scanner, while data from the last 5 patients
were acquired on a separate, but identical, scanner during the upgradeTable 1
Study participant characteristics. The mean and standard deviation are presented for
clinical variables measured at baseline in CAD patients and controls.
Variable Controls
(n = 21)
Pre-CR CAD patients
(n= 39)
Age 59 ± 8 59± 7
Gender (men/women) 11/10 28/11
BMI 24.8 ± 3.3 29.8 ± 4.7a
Fasting blood glucose (mmol/L) 4.75 ± 0.88 5.23± 1.32
Total cholesterol (mmol/L) 4.17 ± 0.94 3.16± 0.79a
hsCRP (mg/L) 0.95 ± 0.89 2.25± 3.10a
Rest supine systolic blood pressure
(mmHg)
121 ± 16 127 ± 22
Rest supine diastolic blood pressure
(mmHg)
69 ± 8 71± 12
Left ventricular ejection fraction (%) 68 ± 9 64± 8
Resting heart rate (beats per minute) 59 ± 10 59± 7
MoCA 28.16 ± 1.7 26.86 ± 2.1a
VO2max (mL/min/kg) 37 ± 2 26± 2a
a Statistical difference between groups at p b 0.05.of the ﬁrst one. All control subjects and 18 CAD patients completed
the graded exercise testing with cardiorespiratory measures to
maximum volitional exhaustion to establish maximal oxygen uptake
(VO2max).
The CAD group comprised of patients with clinical diagnosis at
referral of angina (12.1%), myocardial infract (12.1%) and coronary
artery disease (69.7%). All patients were on a combination of drug
therapy and 36.8% had percutaneous coronary intervention while 7.9%
received coronary artery bypass grafting. Drug therapy included choles-
terol lowering/statins (87.2%), beta-blockers (76.9%), ACE-inhibitors/
angiotensin II receptor blockers (56.4%) and anti-platelets including
aspirin (84.6%). There were no signiﬁcant interactions between gender
and group for any of the clinical measures, includingmarkers of ﬁtness.
No signiﬁcant differences between patients and controls were found for
measures of blood pressure, cardiac output, left ventricular ejection
fraction, resting heart rate and blood glucose. However, compared
to control, CAD patients had lower MOCA scores (F=4.3 (1,53),
p b 0.05), lower VO2max (F= 17.04 (1,53), p b 0.001), lower total
cholesterol levels (F=16.22 (1,56), p b 0.001), elevated body mass
index, BMI (F=17.86 (1,56), p b 0.001), and increased hsCRP levels
(F= 7.40 (1,55), p b 0.01). There was also signiﬁcant difference in
level of education (p= 0.031), as deﬁned by the number of years
of formal education, between patients (15.5 ± 2.7 years) and con-
trols (18.3 ±4.3 years).
VBM results of regional GMV differences between patients and con-
trols are shown in Fig. 1, and the corresponding MNI coordinates and
Talairach anatomical labels are listed in Table 2. In general, the CAD
patient group exhibited signiﬁcantly lower GMV in the frontal lobe, pa-
rietal lobe, temporal lobe, and cerebellum. Therewas a signiﬁcant differ-
ence in total GMV (F=5.5 (1, 53), p b 0.05) between groups but no
statistical difference in total intracranial volume. There were moderate
positive associations between VO2max and total GMV (ρ=0.420(38),
p b 0.001), and GMV in the left posterior cerebellum (ρ=0.616 (38),
p b 0.001) and right post central gyrus (ρ= 0.403 (38), p b 0.01).
There was no signiﬁcant gender-by-group interaction, nor was there
any correlation between total/regional GMV and MoCA scores or any
other clinical parameter measured. Repeating the VBM analysis after
removing the data from the 5 patients acquired on the second system
had no effect on these results, except to reduce the effect size of the
observed regional changes by 5 ± 13%.3.2. Effects of cardiac rehabilitation
Twenty-four CAD patients (18 men and 6 women) completed the
6-monthCR program and post-CR testing. The MRI data, pre and post-
rehabilitation, from the last ﬁve patients were acquired on the second
scanner. Fifteen patients completed graded exercise testing to maxi-
mum volitional exhaustion on entry and exit from the CR program.
No statistically signiﬁcant differences were found in any of the clinical
parameters between the pre and post-CR tests. In addition, there was
no change in MoCA scores (p=0.3) after 6 months of CR. There was a
trend (5%) towards increased VO2max (p= 0.06) in the 15 patients
tested after 6 months of CR.
Regions of positive change in GMV from VBM analysis of CAD pa-
tients, pre and post-CR, are listed in Table 3 and displayed on Fig. 2.
The main increases in GMV after 6 months of CR were observed bilater-
ally in the frontal lobe, middle temporal gyrus and supplementary
motor area (Table 3). Small clusters of increase in GMV were observed
in some of the regions affected by CAD (see Table 4), signifying a recov-
ery of volume following CR. There was no change in total GMV or total
intracranial volume after CR. No signiﬁcant correlation was found
between VO2max post CR and regional GMV and between change in
VO2max and regional increase in GMV. There was no signiﬁcant
scanner-by-time interaction or gender-by-time interaction (p b 0.05,
FWE) and no difference in GMV or clinical measures between patients
Fig. 1. Differences in GMV between CAD patients and age-matched controls measured at baseline. t-Statistics displayed on a rendered model of a single subject brain. The red blobs on
coronal, sagittal and transverse planes indicate areas of decreased GMV in the CAD patient group.
Table 2
Localmaxima of clusters of signiﬁcant change inGMvolume in the pre-CRCAD patient group compared to controls. Coordinates are given in anatomicalMNI space andmaxima are shown
at least 8.0 mm apart. The center of mass of each ROI is shown in bold. (Corrected for multiple comparisons (FDR, p b 0.05).
Cluster Number Volume (mm) Anatomical label Brodmann area MNI coordinate t-Value
x y z
1 2688 L superior frontal gyrus 10 −22 57 −10 5.03
L SFG 10 −18 55 −23 3.00
L MFG 11 −27 45 −6 4.66
2 1831 R superior frontal gyrus 10 18 58 −10 4.96
L frontal lobe (rectal gyrus) 11 0 48 −23 4.76
R SFG 10 14 54 −15 3.81
3 1515 L posterior cerebellum NA −40 −68 −12 4.90
4 510 R posterior cerebellum NA 3 −73 −3 4.73
5 799 R medial frontal gyrus 9 9 47 29 4.64
L medial frontal gyrus 8 −6 45 29 3.74
6 674 R inferior frontal gyrus 47 42 15 −3 4.52
7 977 L parietal lobe (post central gyrus) 40 −56 −20 19 4.42
L Frontal (precentral gyrus) 4 −51 −13 42 3.74
8 202 L inferior frontal gyrus 44 −53 4 16 4.41
L parietal (precentral) 4 52 −5 15 3.50
9 774 R orbitofrontal 11 22 38 −22 4.33
10 1601 L IFG 47 −42 28 −1 4.31
L Insula −33 17 0 4.01
11 134 L inferior parietal gyrus 40 −42 −36 41 4.13
12 518 R inferior parietal lobe 40 51 −33 40 4.07
13 83 L middle temporal gyrus 37 −51 −55 0 4.02
14 127 R superior parietal gyrus 7 24 −58 61 3.96
15 141 L temporal lobe (Fusiform) 37 −50 −42 −10 3.71
16 270 L superior temporal gyrus 38 −33 5 −17 3.63
17 50 R superior temporal gyrus 38 44 3 −19 3.50
18 69 R inferior temporal gyrus 20 39 −22 −31 3.45
19 74 R anterior cingulate gyrus (dorsolateral) 32 6 25 30 3.38
L = left; R = right; SFG= superior frontal gyrus; MFG=medial frontal gyrus; IFG = inferior frontal gyrus.
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Table 3
Localmaxima of clusters of signiﬁcant change in GMvolume in the CAD post CR (Post N Pre). Coordinates are given in anatomicalMNI space, andmaxima shown are at least 8.0 mmapart.
The center of mass of each ROI is shown in bold. Corrected for multiple comparisons (FWE, p b 0.05).
Cluster Number Volume (mm) Anatomical label Brodmann Area MNI Coordinate t-Value
x y z
1 1095 Right frontal (paracentral) lobe 6 8 −33 66 13.67
2 304 Left middle temporal gyrus 21 −62 −60 9 11.63
3 504 Left frontal (paracentral) lobe 6 −8 −28 66 10.70
4 782 Right anterior cerebellum NA 3 −55 4 10.37
Left posterior cerebellum NA 0 −73 −8 8.92
Left cerebellum NA −8 −81 −15 8.44
5 191 Right superior frontal gyrus 10 22 63 −8 10.26
6 122 Left inferior temporal gyrus 20 −32 0 −47 8.88
7 1175 Right superior temporal 38 22 8 −45 8.88
8 427 Right superior temporal 22 64 −42 10 8.12
Right middle temporal gyrus 22 66 −34 4 7.84
9 246 Right frontal (precentral) gyrus 6 56 0 31 7.79
10 28 Left superior temporal gyrus 22 −56 11 −2 7.33
11 54 Left medial frontal gyrus 10 −3 66 6 7.27
13 93 Right medial frontal gyrus 6 4 −19 54 7.13
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unable to.
4. Discussion
The key ﬁndings of the current study were lower GMV in the pre-
frontal cortex, parietal and temporal lobes of CAD patients comparedFig. 2.GMV changes over time in CAD patient pre and post CR. t-Static displayed on a renderedm
areas of increased GMV in the CAD group after 6 months of CR.to age-matched controls (Fig. 1 and Table 2) and increased GMV in
the superior frontal gyrus, medial frontal gryus and superior tempo-
ral gryus after 6 months of cardiovascular rehabilitation (Fig. 2 and
Table 3). This study is the ﬁrst to show evidence of regional cortical
brain atrophy associated with cardiovascular disease and also the
ability of cardiovascular rehabilitation to reverse disease-related
cortical atrophy.odel of a single subject brain. Red blobs on coronal, sagittal and transverse planes indicate
Table 4
Cluster of GMV recovery after 6 months of CR (N= 24). Small volume correction
(p b 0.05, FWE).
Cluster
Number
Volume
(mm)
Anatomical label Brodmann
Area
MNI Coordinate t-Value
x y z
1 128 Right superior frontal
gyrus
11 22 61 −10 10.26
2 23 Right middle temporal
gyrus
22 67 −37 13 7.20
3 99 Left posterior cerebellum
(declive of vermis)
NA 0 −72 −3 8.92
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Our CAD group was composed of patients diagnosed with either
angina or myocardial infarction who were all receiving some form of
treatment prior to the start of the study. Most patients were on a com-
bination of drug therapy to lower lipid levels, to maintain blood pres-
sure, and to prevent reinfarction. The therapeutic impact of these
treatments might have contributed to the lack of any statistical differ-
ences in fasting blood glucose, resting supine blood pressure, cardiac
output or heart rate between patients and controls. The CAD patients
had lower lipid levels compared to controls, which can be attributed
to the efﬁcacy of statins in reducing serum levels of cholesterol
(Cholesterol Treatment Trialists' (CTT) Collaborators et al., 2012). How-
ever, mean hsCRP, a marker of inﬂammation associated with increased
risk of myocardial infarct or reinfarction, was higher for CAD patients
than controls.
4.2. CAD-related effects: Brain atrophy
The ﬁndings of decreased GMV in the frontal, temporal and parietal
lobes of CAD patients are similar to the patterns of brain atrophy previ-
ously observed in patients with either hypertension or diabetes, in
which marked declines in GMV were found in the prefrontal cortex, su-
perior temporal andmiddle temporal lobes, thalamus, and hippocampus
(De Toledo Ferraz Alves et al., 2010). The regions common to all of these
studies are associated with varying cognitive functions – executive func-
tion, attention, and memory, visuospatial and psychomotor speed – and
are believed to be susceptible to vascular disease (Nordlund et al., 2007).
A study of 400 men over the age of 40 found that cardiovascular dis-
ease was associated with poor performance in memory tests and a
trend towards lower scores in mini-mental state examination (MMSE)
(Muller et al., 2007). Similarly, Okonkwo et al. (2010) reported an accel-
erated decline in the aforementioned cognitive domains in a large group
of cardiovascular disease patients over a three year period that was not
attributed to aging. In addition, numerous studies have linked markers
of cardiovascular disease including impaired vascular hemodynamics
(pulse wave variability, arterial stiffness, and ventricular function) to
alterations in cognitive function (Fujiwara et al., 2005; Wendell et al.,
2009). In general, the observation of decreased GMV in the frontal, tem-
poral and parietal lobes indicates that CAD accelerates age-related neo-
cortical degeneration, possibly leading to a declining cognitive function.
Our ﬁndings of bilateral atrophy in the posterior cerebellum and in the
inferior parietal lobule of the brain in the CAD group is novel given that
these regions are usually preservedwith age and atrophy has only been re-
ported in a few dementia studies (Greene et al., 2010; Yoon et al., 2013).
These studies linked poor performance on short-term memory and
visuospatial tasks to GMV decline in either the cerebellum (Yoon et al.,
2013) or the inferior parietal lobule (Greene et al., 2010), highlighting the
known importance of both regions in neurocognitive integration. Taken
together, these observations suggest that in older adults, cardiovascular
disease can precipitate changes in normally stable regions of the brain.
A signiﬁcant difference in mean baseline MoCA scores between the
CAD group and controls was found in the current study (Table 1). 24%
of CAD patients had a score of 25 or less compared to 5% of controls.AMoCA score of less than 26 is typically considered to reﬂect mild cog-
nitive impairment (MCI). However, there was no correlation between
MoCA scores and regional brain atrophy. Considering the MoCA is a
brief assessment tool of MCI (Nasreddine et al., 2005), it may not be
ideal for probing subtle cognitive decline in middle-aged adults since
evidence of cognitive decline typically occurs after the age of 60
(Hedden and Gabrieli, 2004). The apparent difference in MoCA scores
between groups could possibly be a mere reﬂection of the difference
in levels of education observed between groups. Education was associ-
ated with performance on MoCA (r=0.518, p b 0.01), but not total or
regional GMV. Similarly, Christensen et al. (2009) found no link be-
tween level of education and global or regional brain atrophy in adults
with no history of cognitive impairments. The use of tests more speciﬁc
to the cognitive functions associated with the observed areas of brain
atrophy might reveal greater impairment. Nonetheless, the current
data support the overall concern that CAD accelerates cortical atrophy
with detrimental outcomes to cognitive ability.
The directmechanism(s) that drive the greater brain atrophy associ-
ated with cardiovascular disease are unclear. One possible mechanism
could involve cerebral hypoperfusion. Animal studies have shown that
cerebral hypoperfusion from ischemic vessels can initiate pathophysio-
logical changes in the brain structure and function of aging rats,
resulting in decreased synaptic activity and impaired memory and
visuospatial skills (De la Torre, 2000). Human studies of diabetic and
hypertensive patients have reported regional cerebral hypoperfusion
in similar regions of the brain where atrophy has been reported (Dai
et al., 2008; Last et al., 2007). Investigating cerebral blood ﬂow or
cerebrovascular dynamics with morphometric imaging would help
elucidate potential neurovascular changes in CAD patients.
A common cause underlying both CAD and brain atrophy could be
physical inactivity. Physical inactivity is an important modiﬁable risk
factor for heart disease given that inactive individuals are twice as likely
to suffer a coronary event in their lifetime compared to physically active
individuals (Powell et al., 1987). In this study, the CAD patients were
40% less ﬁt than controls and the less ﬁt individuals were more likely
to have lower global and regional GMV. In general, physical inactivity
is associated with regional brain atrophy (Yuki et al., 2012) and cogni-
tive decline (Barnes et al., 2003) in healthy older adults.
4.3. Effect of rehabilitation: Neuroplasticity
The propensity for age and CAD to adversely affect the function and
morphology of certain regions of the brain, namely the prefrontal,
superior parietal, inferior temporal and middle temporal, suggests that
these regions are highly malleable and perhaps more adaptive to
change. Recovery of volume within these brain regions with exercise
in both healthy aging subjects and dementia patients signiﬁes that
these regions are highly plastic (Colcombe et al., 2004; Erickson et al.,
2012; McAuley et al., 2004). These observations are in good agreement
with our ﬁnding of increased GMV in the prefrontal, left middle
temporal, left inferior temporal lobes in addition to the cerebellum,
supplementary motor areas and right superior temporal gyrus of
CAD patients after 6 months of CR.
The signiﬁcance of aerobic ﬁtness in improving cardiovascular and
cerebral functions is well established and discussed in great detail in
reviews by Erickson et al. (2010) and Lavie et al. (2009). Brieﬂy, with
CAD, aerobic ﬁtness is associated with a signiﬁcant decrease in relative
risk of mortality, improved ventricular function, and improved vascular
dynamics (Baker et al., 2010). In older adults and dementia patients, exer-
cise training was associated with increases in regional brain volume, im-
proved cognitive function, and increased neuronal activity (Lavie et al.,
2009). Increases in regional GMV (Colcombe et al., 2006; Lautenschlager
et al., 2008) and cognitive function (Erickson et al., 2010) have been re-
ported after 6 months of moderate level of exercise training (40–70% of
heart rate reserve). The prescribed 6 months of aerobic exercise, as part
of the CR program, was sufﬁcient to cause detectable changes in brain
394 U.C. Anazodo et al. / NeuroImage: Clinical 3 (2013) 388–395structures of CAD patients including changes in non-motor areas, despite
the observed modest impact on aerobic ﬁtness.
Findings of recovery of GMV in areas of the superior frontal lobe,
superior temporal lobe and posterior cerebellum (Table 4) after a short
period of exercise are promising and indicate a unique positive outcome
of CR. It could be postulated that the recovery of brain volume in these re-
gions could potentially bemaintained over longer periods. Erickson et al.
(2010) found retention of regional brain volume in older adults that per-
formed low intensity exercise nine years after cessation of the activity.
4.4. Study consideration
The impact of cardiac artery bypass grafting surgery (CABG) on neu-
roanatomy and cognitive function cannot be ignored. CABG is known to
exert transient decrease in brain volume and cognitive function (Selnes
and McKhann, 2005). The interaction between cardiovascular disease
and CABG on regional GMV was not explored given that only 8% of
CAD patients in this study underwent CABG and this occurred a few
months prior to the start of the study.
It is possible that theGMVchanges observedpost-CR inCADpatients
might not reﬂect the full potential neurorehabilitatory beneﬁts of CR
giving the moderate improvement in GMV post exercise training.
Considerable changes could be achieved with either high-intensity
aerobic exercises or activities such as basket ball, hockey or squash
that incorporate motor skills along with cognitive and perceptual skills
(areas which showed signiﬁcant GMV decline with CAD). The lack of
association between VO2max and GMV could be a result of the large
number of patients who were unable to complete the graded exercise
test for various reasons including the inability to reach maximal voli-
tional exhaustion, which is common among CAD patients. Submaximal
graded exercise tests or a 6 minute walk test could be used to evaluate
cardiorespiratory capacity in CAD patientswho cannot achievemaximal
myocardial oxygen uptake. However, submaximal VO2 tests often lack
diagnostic accuracy, particularly tests that exclude heart rate measures
with electrocardiography.
The innate methodological limitations of VBM are also drawbacks to
the interpretation of our ﬁndings. The registration, segmentation and
normalization steps in VBM can introduce bias and distortion errors
particularly in the border of small subcortical GM structures where
some proximal voxels can be misclassiﬁed (Ashburner and Friston,
2000; Good et al., 2001). This error is exaggerated in older brains
prone to enlarged ventricles. We minimized these distortion errors
with the use of a study-speciﬁc template and DARTEL registration
method (Ashburner, 2007; Good et al., 2001). However, this inherent
segmentation and registration bias can pose a limitation to the investi-
gation of CAD-related regional brain volume changes in vulnerable sub-
cortical regions such as the hippocampuswhere decline in volume have
been previously reported in CAD (Koschack and Irle, 2005). For longitu-
dinal studies, available intra-subject bias correctionmethods attempt to
minimize the inﬂuence of baseline differences on images from sub-
sequent time points. However, issues of registration asymmetry can
be largely improved with symmetric diffeomorphic approaches pro-
posed for future versions of SPM, particularly for non-quantitative T1-
imaging data (Ashburner and Ridgway, 2013).
A potential limitation with this study was the use of two scanners in
data acquisition. However, performing the analysis of the effects of CAD
without the ﬁve patients imaged on the second scanner revealed no dif-
ference in the pattern of regional GMV differences reported in Table 2
and shown in Fig. 1. Furthermore no signiﬁcant effect was found by
including scanner as a between-subject factor in the analysis of the
rehabilitation data.
5. Conclusion
This study demonstrates that in stable CAD patients, cardiovascular
disease is associated with brain atrophy in several brain regions,including those related to cognitive ability. This disease-related effect
appears to be reversible as this study demonstrated that a modest
aerobic program reversed some of the structural abnormalities.Role of the funding source
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